Food and Drug Administration, Dockets Management Branch, 5630 Fishers Lane - Room 1061- HFA-305, Rockville, MD, 20852; 301-827-6860; Fax 301-827-6870 [E-mail Us] DOCKETS ENTERED on October 2, 2001 TABLE OF CONTENTS Hyper links are part of the Docket title - not all dockets/documents are linked NOTE: Documents received by the Dockets Management Branch "MAY" be posted on the Internet.PLEASE DO NOT include personal identifying information, i.e. date of birth, social security number, etc., in your correspondence. |
|
74P-0001 Vinyl Chloride as ingredient Drug/Cosmetic Aerosol Products
C 4 C. Ruggles Vol#: 1
C 5 Vick Divisions Research Vol#: 1
C 6 The J. B. Williams Company, Inc. Vol#: 1
C 7 American Meat Institute Vol#: 1
C 8 Travenol Laboratories, Inc. Vol#: 1
C 9 The Cosmetic,Toilety & Fragrance Assn. Vol#: 1
C 10 American Meat Institute Vol#: 1
C 11 Ernest D. Eason Vol#: 1
C 12 Union Carbide Corporation Vol#: 1
C 13 E. Fontenot Vol#: 2
C 14 Ernestine Finkins Vol#: 2
C 15 Barbara Talmadge Vol#: 2
C 16 Peter Psaltis Vol#: 2
C 17 Mr. & Mrs. Scott Doup Vol#: 2
C 18 Joseph K. Cooney Vol#: 2
C 19 J. E. Lieb Vol#: 2
C 20 Bristol-Myers Products Vol#: 2
C 21 Abbott Laboratories Vol#: 2
C 22 Jeanne M. Maier Vol#: 2
C 23 Continental Oil Company Vol#: 2
NPR 2 Vol#: 2
94D-0025 Interim GDL/Labeling Milk & Milk Products from Cows w/rbST
C 8563 Garrett Stults Vol#: 116
C 8564 Kate Wilsmann Vol#: 116
C 8565 Allen Salyer Vol#: 116
C 8566 C. Gopinath Vol#: 116
C 8567 Jessica McGinnis Vol#: 116
C 8568 Mary Ann Bergeson Vol#: 116
C 8569 Bill and Judith Bianchi Vol#: 116
C 8570 Eric S. Johnson Vol#: 116
C 8571 Charlie Murdach, MA, A.T.,C. Vol#: 116
C 8572 Amanda C. Goad Vol#: 116
C 8573 Mary Anna Biedermann Vol#: 116
C 8574 Darlene L. Mann Vol#: 116
C 8575 Ruby Fleet Vol#: 116
C 8576 Mrs Leo R. Berger Vol#: 116
C 8577 P.S. Molloy Vol#: 116
C 8578 Lonise Waters Vol#: 116
96P-0484 Rotating Membrane Filtration Blood Cell Separation Systems
PAV 1 HFM-300 to Steven Binion, PhD Vol#: 3
97D-0318 Revised Precautionary Measure to Reduce Transmission of CJD
C 19 Alpha Therapeutic Corporation Vol#: 1
C 20 San Diego Blood Bank Vol#: 1
C 21 New York Blood Center Vol#: 1
C 22 Blood Systems, Inc. Vol#: 1
EXT 5 Sera-Tec Biologicals Vol#: 1
99P-1864 Reclassify Constrained Hip Prosthesis Metal/Polymer
00D-1598 Voluntary Labeling for Bioengineered Foods
C 9499 Form Letter count 2,038 Vol#: 508
C 9500 Tamara Ellen-Hess Shields Vol#: 476
C 9501 Form Letter Count 1,411 Vol#: 509
C 9502 Form Letter Count 10 Signatures Vol#: 512
C 9503 Form Letter Count 6,560 Signatures Vol#: 513
C 9504 Form Letter count 120 Vol#: 514
00E-1250 Patent Extension Synercid #4,798,827
N 1 Vol#: 1
00N-0074 Safeguards for Children Clinical Ivestigations FDA-Regulated
LET 1 HF-40 to Representive Bonnie Ladwig Vol#: 1
00P-0586 Amend Pt 133.3 re:Milk and Nonfat Milk for use in Standardiz
C 26 National Farmers Union Vol#: 2
00P-1322 Food Labeling and Allergen Contamination Control
C 412 Lisa M. Scott Vol#: 25
00P-1499 Remove alosetron (Lotronex) from the market
C 183 John J. Kravitz, MD, F.A.C.G. Vol#: 5
01D-0297 Avail. of Info Given to Advisory Committee Members CDRH
01N-0196 Phenylpropanolamine proposal to withdraw approval of NDA
C 6 Levin, Fishbein, Sedran & Berman Vol#: 1
01N-0370 Progress on implementing for the common technical document
N 1 Vol#: 1
01N-0384 Global Harmonization task Force Conference in Spain
N 1 Vol#: 1
01P-0122 To Remove False and Deceptive Labeling for Transderm Scop
C 2 Novartis Consumer Health, Inc. Vol#: 2
01P-0449 ANDA Suitability for Digoxin Elixir, 0.05 mg/mL